Country: Ամերիկայի Միացյալ Նահանգներ
language: անգլերեն
source: NLM (National Library of Medicine)
meloxicam (UNII: VG2QF83CGL) (meloxicam - UNII:VG2QF83CGL)
HENRY SCHEIN ANIMAL HEALTH
meloxicam
meloxicam 1.5 mg in 1 mL
ORAL
PRESCRIPTION
EloxiOral Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. Dogs with known hypersensitivity to meloxicam should not receive EloxiOral Oral Suspension. Do not use EloxiOral Oral Suspension in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.
EloxiOral Oral Suspension 1.5 mg/mL: 10, 32 and 100 mL bottles with small and large dosing syringes. Storage: Store at controlled room temperature 68-77°F (20-25°C). Excursions permitted between 59°F and 86°F (15°C and 30°C). Brief exposure to temperature up to 104° F (40°C) may be tolerated provided the mean kinetic temperature does not exceed 77°F (25°C); however such exposure should be minimized. Distributed Exclusively by: Henry Schein Animal Health Dublin, OH 43017 www.henryscheinvet.com Made in the UK. Manufactured by: Norbrook ® Laboratories Limited Newry, Co. Down, BT35 6PU Northern Ireland
Abbreviated New Animal Drug Application
ELOXIORAL- MELOXICAM SUSPENSION HENRY SCHEIN ANIMAL HEALTH ---------- HENRY SCHEIN ANIMAL HEALTH PROFESSIONAL INSERT ANADA 200-497, Approved by FDA ELOXIORAL™ (MELOXICAM) 1.5 MG/ML ORAL SUSPENSION Non-steroidal anti-inflammatory drug for oral use in dogs only CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. WARNING: Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. See Contraindications, Warnings, and Precautions for detailed information. DES CRIPTION: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. Each milliliter of EloxiOral Oral Suspension contains meloxicam equivalent to 1.5 milligrams and sodium benzoate (1.5 milligrams) as a preservative. The chemical name for Meloxicam is -Hydroxy-2-methyl-N-(5-methyl-2- thiazolyl)-2H-1,2-benzothiazine-3-carbox-amide-1, 1-dioxide. The formulation is a yellowish viscous suspension. INDICATIONS : EloxiOral Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. DOSAGE AND ADMINISTRATION: Always provide client information sheet with prescription. Carefully consider the potential benefits and risk of EloxiOral Oral Suspension and other treatment options before deciding to use EloxiOral Oral Suspension. Use the lowest effective dose for the shortest duration consistent with individual response. EloxiOral Oral Suspension should be administered initially at 0.09 mg/lb (0.2 mg/kg) body weight only on the first day of treatment. For all treatments after day 1, EloxiOral Oral Suspension should be administered once daily at a dose of 0.045 mg/lb (0.1 mg/ kg). The syringes are calibrated to deliver the daily maintenance dose in lbs. Because the first dose (0.2 mg/kg) is two times the amount of the daily maintenance dose (0.1 mg/kg), two syringes containing the 0.1 mg/kg dose should be administered at the first dose. ® TM DIRECTIONS FOR ADMINISTR read_full_document